These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group. J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703 [Abstract] [Full Text] [Related]
6. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci. Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR. Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924 [Abstract] [Full Text] [Related]
9. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center. Smith PF, Booker BM, Ogundele AB, Kelchin P. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606 [Abstract] [Full Text] [Related]
18. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005). Lee DK, Kim Y, Park KS, Yang JW, Kim K, Ha NJ. J Biochem Mol Biol; 2007 Nov 30; 40(6):881-7. PubMed ID: 18047782 [Abstract] [Full Text] [Related]
19. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin. Rathe M, Kristensen L, Ellermann-Eriksen S, Thomsen MK, Schumacher H. APMIS; 2010 Jan 30; 118(1):66-73. PubMed ID: 20041873 [Abstract] [Full Text] [Related]
20. Gram-positive bacterial resistance. A challenge for the next millennium. Bassetti M, Melica G, Cenderello G, Rosso R, Di Biagio A, Bassetti D. Panminerva Med; 2002 Sep 30; 44(3):179-84. PubMed ID: 12094131 [Abstract] [Full Text] [Related] Page: [Next] [New Search]